Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #39,401 to #39,450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Valproic acid capsule/solution use in specific populations (2 revisions)
  2. Valproic acid capsule delayed release clinical pharmacology (2 revisions)
  3. Valproic acid capsule delayed release contraindications (2 revisions)
  4. Valproic acid capsule delayed release description (2 revisions)
  5. Valproic acid capsule delayed release dosage and administration (2 revisions)
  6. Valproic acid capsule delayed release dosage forms and strengths (2 revisions)
  7. Valproic acid capsule delayed release drug interactions (2 revisions)
  8. Valproic acid capsule delayed release how supplied storage and handling (2 revisions)
  9. Valproic acid capsule delayed release labels and packages (2 revisions)
  10. Valproic acid capsule delayed release nonclinical toxicology (2 revisions)
  11. Valproic acid capsule delayed release overdosage (2 revisions)
  12. Valproic acid capsule delayed release patient counseling information (2 revisions)
  13. Valproic acid capsule delayed release use in specific populations (2 revisions)
  14. Valtumumab (2 revisions)
  15. Valve of the inferior vena cava (2 revisions)
  16. Valve replacement (2 revisions)
  17. Valvular stenosis (2 revisions)
  18. Vamorolone (2 revisions)
  19. Van der Waals force (2 revisions)
  20. Vancomycin-resistant Staphylococcus aureus CT (2 revisions)
  21. Vancomycin-resistant Staphylococcus aureus MRI (2 revisions)
  22. Vancomycin-resistant Staphylococcus aureus case study one (2 revisions)
  23. Vancomycin-resistant Staphylococcus aureus causes (2 revisions)
  24. Vancomycin-resistant Staphylococcus aureus chest x ray (2 revisions)
  25. Vancomycin-resistant Staphylococcus aureus classification (2 revisions)
  26. Vancomycin-resistant Staphylococcus aureus cost-effectiveness of therapy (2 revisions)
  27. Vancomycin-resistant Staphylococcus aureus echocardiography or ultrasound (2 revisions)
  28. Vancomycin-resistant Staphylococcus aureus epidemiology and demographics (2 revisions)
  29. Vancomycin-resistant Staphylococcus aureus future or investigational therapies (2 revisions)
  30. Vancomycin-resistant Staphylococcus aureus history and symptoms (2 revisions)
  31. Vancomycin-resistant Staphylococcus aureus natural history, complications and prognosis (2 revisions)
  32. Vancomycin-resistant Staphylococcus aureus other diagnostic studies (2 revisions)
  33. Vancomycin-resistant Staphylococcus aureus other imaging findings (2 revisions)
  34. Vancomycin-resistant Staphylococcus aureus physical examination (2 revisions)
  35. Vancomycin-resistant Staphylococcus aureus secondary prevention (2 revisions)
  36. Vancomycin-resistant Staphylococcus aureus surgery (2 revisions)
  37. Vancomycin-resistant enterococci CT (2 revisions)
  38. Vancomycin-resistant enterococci MRI (2 revisions)
  39. Vancomycin-resistant enterococci case study one (2 revisions)
  40. Vancomycin-resistant enterococci causes (2 revisions)
  41. Vancomycin-resistant enterococci cost-effectiveness of therapy (2 revisions)
  42. Vancomycin-resistant enterococci differential diagnosis (2 revisions)
  43. Vancomycin-resistant enterococci echocardiography or ultrasound (2 revisions)
  44. Vancomycin-resistant enterococci future or investigational therapies (2 revisions)
  45. Vancomycin-resistant enterococci history and symptoms (2 revisions)
  46. Vancomycin-resistant enterococci medical therapy (2 revisions)
  47. Vancomycin-resistant enterococci natural history, complications and prognosis (2 revisions)
  48. Vancomycin-resistant enterococci other diagnostic studies (2 revisions)
  49. Vancomycin-resistant enterococci other imaging findings (2 revisions)
  50. Vancomycin-resistant enterococci physical examination (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)